Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Delacourte

Showing results (51-60 of 186) with videos related to

Pageof 19
Sort By:
Journal of Alzheimer'S Disease : JAD|September 6, 2002
Sequence of neurofibrillary changes in aging and Alzheimer's disease: A confocal study with phospho-tau antibody, AD2M. Galván, J.P. David, A. Delacourte, et al.
Journal of Neuroscience Research|February 15, 2001
Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cellsS Guise, D Braguer, G Carles, et al.
Neuroscience Letters|March 15, 1996
Dephosphorylation studies of SKNSH-SY 5Y cell Tau proteins by endogenous phosphatase activityC Soulié, J Lépagnol, A Delacourte, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 1, 1989
Alzheimer's disease: glycolytic pretreatment dramatically enhances immunolabeling of senile plaques and cerebrovascular amyloid substanceN Behrouz, A Defossez, A Delacourte, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 12, 1998
Influence and optimisation of operating parameters with a new binder in wet granulation. I: use in powder formP Soyeux, A Delacourte, B Delie, et al.
Pharmaceutica Acta Helvetiae|January 1, 1975
[A technique for the simplified study of powder dispersion resolved by compression]B Devise, A Delacourte-Thibaut, J C Guyot, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1989
[Alzheimer's disease: immunohistochemical characterization of cerebral amyloid deposits]N Behrouz, A Defossez, A Delacourte, et al.
Journal De Pharmacie De Belgique|November 1, 1974
[Formation of tablets with the aid of chain extensiometry. II. Methodology of formulation]A Delacourte-Thibaut, B Devise, J C Guyot, et al.
Annals of Neurology|March 4, 1998
Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylationA Delacourte, N Sergeant, A Wattez, et al.
The Biochemical Journal|November 1, 1980
Study of the 10-nm-filament fraction isolated during the standard microtubule preparationA Delacourte, G Filliatreau, F Boutteau, et al.
Pageof 19

Showing results (51-60 of 186) with videos related to

Sort By:
Pageof 19
Journal of Alzheimer'S Disease : JAD|September 6, 2002
Sequence of neurofibrillary changes in aging and Alzheimer's disease: A confocal study with phospho-tau antibody, AD2M. Galván, J.P. David, A. Delacourte, et al.
Journal of Neuroscience Research|February 15, 2001
Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cellsS Guise, D Braguer, G Carles, et al.
Neuroscience Letters|March 15, 1996
Dephosphorylation studies of SKNSH-SY 5Y cell Tau proteins by endogenous phosphatase activityC Soulié, J Lépagnol, A Delacourte, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 1, 1989
Alzheimer's disease: glycolytic pretreatment dramatically enhances immunolabeling of senile plaques and cerebrovascular amyloid substanceN Behrouz, A Defossez, A Delacourte, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 12, 1998
Influence and optimisation of operating parameters with a new binder in wet granulation. I: use in powder formP Soyeux, A Delacourte, B Delie, et al.
Pharmaceutica Acta Helvetiae|January 1, 1975
[A technique for the simplified study of powder dispersion resolved by compression]B Devise, A Delacourte-Thibaut, J C Guyot, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1989
[Alzheimer's disease: immunohistochemical characterization of cerebral amyloid deposits]N Behrouz, A Defossez, A Delacourte, et al.
Journal De Pharmacie De Belgique|November 1, 1974
[Formation of tablets with the aid of chain extensiometry. II. Methodology of formulation]A Delacourte-Thibaut, B Devise, J C Guyot, et al.
Annals of Neurology|March 4, 1998
Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylationA Delacourte, N Sergeant, A Wattez, et al.
The Biochemical Journal|November 1, 1980
Study of the 10-nm-filament fraction isolated during the standard microtubule preparationA Delacourte, G Filliatreau, F Boutteau, et al.
Pageof 19